Atara Biotherap (ATRA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 06-2026 | 03-2026 | 12-2025 | 09-2025 | 06-2025 | |
| Sales | 630 | 516 | 1,595 | 3,453 | 17,575 |
| Cost of Goods | 191 | 124 | 104 | 115 | 554 |
| Gross Profit | 439 | 392 | 1,491 | 3,338 | 17,021 |
| Operating Expenses | 5,350 | 3,885 | 4,158 | 7,027 | 14,378 |
| Operating Income | -4,720 | -3,369 | -2,563 | -3,574 | 3,197 |
| Interest Expense | 191 | 830 | 894 | 909 | 972 |
| Other Income | 78 | 54 | 51 | 208 | 165 |
| Pre-tax Income | -4,833 | -4,145 | -3,406 | -4,275 | 2,390 |
| Income Tax | 1 | N/A | 0 | 28 | 3 |
| Net Income Continuous | -4,834 | -4,145 | -3,406 | -4,303 | 2,387 |
| Net Income | $-4,834 | $-4,145 | $-3,406 | $-4,303 | $2,387 |
| EPS Basic Total Ops | -0.32 | -0.29 | -0.80 | -0.32 | 0.20 |
| EPS Basic Continuous Ops | -0.32 | -0.29 | -0.80 | -0.32 | 0.20 |
| EPS Diluted Total Ops | -0.32 | -0.29 | -0.80 | -0.32 | 0.19 |
| EPS Diluted Continuous Ops | -0.32 | -0.29 | -0.81 | -0.32 | 0.19 |
| EPS Diluted Before Non-Recurring Items | N/A | -0.29 | -0.25 | -0.32 | 0.19 |
| EBITDA(a) | $-4,735 | $-3,340 | $-2,430 | $-3,621 | $3,432 |